中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共6条，第1-6条

帮助

条数/页：排序方式：
	YCH1899, a Highly Effective Phthalazin-1(2H)-one Derivative That Overcomes Resistance to Prior PARP Inhibitors 期刊论文 OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2023, 页码: 20 作者: Sun, Yuting; Yang, Hui \| 收藏 \| 浏览/下载：30/0 \| 提交时间：2023/10/17
	Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone 期刊论文 OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 240, 页码: 114574 作者: Kayumov, Muzaffar; Jia, Li; Pardaev, Azizbek; Song, Shan-Shan; Mirzaakhmedov, Sharafitdin \| 收藏 \| 浏览/下载：35/0 \| 提交时间：2024/03/21 PARP1 Olaparib Alantolactone Syntheticlethality BRCA1/2mutant
	Development of Potent NEDD8-Activating Enzyme Inhibitors Bearing a Pyrimidotriazole Scaffold 期刊论文 OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 9, 页码: 6161-6178 作者: Xiong, Chaodong; Zhou, Lina; Tan, Jing; Song, Shanshan; Bao, Xubin \| 收藏 \| 浏览/下载：38/0 \| 提交时间：2021/08/17
	Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, invitro and in human tumor xenograft models 期刊论文 OAI收割 CANCER SCIENCE, 2019, 卷号: 110, 期号: 4, 页码: 1420-1430 作者: Long, Fei; He, Ye; Fu, Haoyu; Li, Yun; Bao, Xubin \| 收藏 \| 浏览/下载：41/0 \| 提交时间：2020/07/01 breast cancer CDK 4/6 drug resistance palbociclib SHR6390
	Combined inhibition of PI3K delta and FLT3 signaling exerts synergistic antitumor activity and overcomes acquired drug resistance in FLT3-activated acute myeloid leukemia 期刊论文 OAI收割 CANCER LETTERS, 2018, 卷号: 420, 页码: 49-59 作者: He, Ye; Sun, Liping; Xu, Yongping; Fu, Li; Li, Yun \| 收藏 \| 浏览/下载：50/0 \| 提交时间：2019/01/08 Acute myeloid leukemia FLT3 PI3K delta CAL101 Synergistic effect
	An efficient design for fast memory registration in RDMA 期刊论文 OAI收割 JOURNAL OF NETWORK AND COMPUTER APPLICATIONS, 2009, 卷号: 32, 期号: 3, 页码: 642-651 作者: Ou, Li; He, Xubin; Han, Jizhong \| 收藏 \| 浏览/下载：19/0 \| 提交时间：2019/12/16 RDMA Memory registration Cache Performance evaluation